What Hope Research Institute does

Hope Research Institute is an independent, for-profit clinical research organization founded in 2002 and headquartered in Phoenix, Arizona. The company operates four sites across the Phoenix metropolitan area (Phoenix, Tempe, Glendale, and a dedicated Phase I unit in Scottsdale) and holds an exclusive research partnership with Freedom Hospital for pain disorder studies. It conducts Phase I-IV clinical trials on behalf of pharmaceutical, biotech, and medical device sponsors across therapeutic areas including vaccines (COVID-19, influenza, RSV, CMV, pneumococcal), cardiology, gastroenterology, pain management, metabolic conditions, and device validation. Hope Research Institute reports 1,000+ completed studies, 80,000+ patient visits, 300,000+ research volunteers, 175+ sponsor partners, and 22 FDA inspections with zero findings; it is also the first independent, private clinical research facility in the nation to hold AAHRPP accreditation.

The company's site infrastructure includes an on-site clinical laboratory, advanced imaging (DEXA, CT, MRI, X-ray, Fibroscan), an infusion center, ECG, vaccine-grade refrigeration including -20°C and -70°C freezers, 24/7 IP temperature monitoring, backup generators, and PBMC isolation capabilities. The Phase I unit adds adaptive trial design, pharmacokinetic assessment, and biomarker analysis capabilities, supported by NIH-certified investigators and ACRP-certified, GCP-certified study coordinators with in-house quality assurance, regulatory, and business development functions.

Hope Research Institute generates revenue through contracted clinical trial services, compensated via per-study fees including per-patient fees, site setup fees, and milestone payments tied to enrollment and data delivery for sponsors. Its go-to-market combines enterprise field sales to pharmaceutical, biotech, and medical device sponsors (and CROs) with a community-led patient acquisition motion that relies on multilingual support, health fair participation, educational workshops, and a network of affiliated Valley physician investigators. Patient enrollment is supported by a self-serve sign-up pathway on hriaz.com and a contact center, with community outreach targeted at diverse and underrepresented populations.

Name

Hope Research Institute

Legal name

Hope Research Institute, LLC

Website

https://hriaz.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Hope Research Institute is an independent, AAHRPP-accredited clinical research site operating four Phoenix-area locations that conducts Phase I-IV clinical trials for 175+ pharmaceutical, biotech, and medical device sponsors, with 1,000+ completed studies and 22 FDA inspections yielding zero findings.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (62151), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Trial Patient Recruitment & Retention (HLAGACAD), Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical trial services
• Phase I-IV research
• Clinical research site
• Vaccine clinical trials
• Patient recruitment services

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Clinical Trial Contract Revenue: Hope Research Institute generates revenue by conducting clinical trials on behalf of pharmaceutical companies, biotech firms, and medical device manufacturers under contract. They are compensated per study, with revenue derived from per-patient fees, site setup fees, and milestone payments tied to enrollment and data delivery. They serve as a contracted research site performing Phase I-IV trials for sponsors.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Hope Research Institute operates as an independent clinical research site conducting Phase I-IV clinical trials on behalf of pharmaceutical, biotech, and medical device sponsors. It delivers end-to-end trial execution services including patient recruitment, on-site clinical laboratory and imaging, regulatory support, data management, quality assurance, and adaptive trial design across multiple therapeutic areas through sites in the Phoenix metropolitan area and a dedicated Phase I unit in Scottsdale.

Product overview

Hope Research Institute operates as a multi-specialty clinical research organization offering comprehensive Phase I-IV clinical trial services across multiple therapeutic areas. The company's portfolio includes dedicated research sites (Phoenix, Tempe, Glendale, and Scottsdale Phase I Unit), a partnership facility at Freedom Hospital, and specialized clinical trials spanning vaccines (COVID-19, Influenza, RSV, CMV, Pneumococcal), pain management, cardiology, gastroenterology, and metabolic conditions. The organization provides end-to-end research services including patient recruitment, regulatory support, in-house data management, quality assurance, and site infrastructure with advanced monitoring capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services
• Phase I Clinical Trial Unit
• Vaccine Clinical Trials

Quantifiable outcome

• 22 FDA inspections with zero findings
• +5 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• Freedom Integrative Specialty Healthcare (Freedom Hospital)coreStrategic or Co-development PartnerHope Research Institute is an exclusive partner for clinical research at Freedom Hospital, part of Freedom Integrative Specialty Healthcare. Freedom Hospital is the first medical campus dedicated to the treatment of pain disorders, and this partnership positions both entities at the forefront of pain research. Freedom Hospital offers dedicated inpatient and outpatient rooms, on-site laboratory services, and imaging capabilities. Central IRBs can be used to facilitate fast start-up and rapid enrollment timelines.
• Pharmaceutical and Device Companies (175+ Sponsors)coreOthersHope Research Institute partners with more than 170 study sponsors (pharmaceutical and device companies) to propel new clinical studies forward. They have conducted successful clinical research for over twenty years, with over 80,000 patient visits and 4 FDA inspections for high-enrolling studies with zero findings.
• CROs (Contract Research Organizations)coreOthersHope Research Institute works with CROs and investigative sites across the country, providing therapeutic expertise, geographic location, and diverse patient populations. The organization actively seeks partnerships with sponsors, CROs, and other stakeholders to foster an environment where shared expertise propels clinical research forward.
• Valley Physician Practices and HospitalscoreStrategic or Co-development PartnerHope Research Institute boasts affiliations from small private practices to large multi-center facilities of experienced Valley physicians with excellent reputations, both in inpatient and outpatient settings. These physician partnerships enable broad therapeutic area coverage and patient access across the region.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Accel Research Sites: Accel Research Sites is a multi-therapeutic SMO operating across multiple US metros with Phase I-IV capabilities, in-house recruitment, and dedicated investigator networks — a direct like-for-like competitor to Hope Research Institute for sponsor contracts.
• Javara: Javara is an Integrated Research Organization (IRO) partnering with health systems and physician practices to embed clinical trial capabilities into clinical care. Directly comparable to Hope's affiliated physician investigator model and community-based recruitment approach.
• Velocity Clinical Research: Velocity Clinical Research is a large, multi-site SMO network operating dedicated research sites across the US for Phase I-IV trials in multiple therapeutic areas. It is directly comparable to Hope Research Institute as a similarly positioned independent site operator competing for the same pharma/biotech sponsor contracts.
• CenExel Clinical Research: CenExel operates a network of clinical research sites specializing in Phase I and early-phase trials, including PK, bioequivalence, and patient population studies. Comparable to Hope's Scottsdale Phase I unit and adaptive trial capabilities, and a direct competitor for early-phase sponsor contracts.

Broad incumbents

• IQVIA (Site Services / Patient Recruitment): IQVIA is the world's largest CRO with an integrated site-management and patient-recruitment arm that competes for sponsor budgets across all therapeutic areas. Comparable as a broader incumbent offering the same Phase I-IV site services as Hope, but at global scale.
• Medpace: Medpace is a mid-to-large global CRO with strong site-management operations and therapeutic expertise in Phase I-IV trials. Comparable as a broader incumbent competing for the same pharma/biotech sponsor contracts that Hope bids on.
• Syneos Health: Syneos Health is a global biopharmaceutical solutions organization combining CRO and site/sponsor services. Comparable to Hope as a broader incumbent with overlapping site-management and clinical operations services across Phase I-IV trials.
• Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a global CRO offering clinical development services including site management, central lab, and diagnostics. Comparable as a broader incumbent that operates site networks and competes for sponsor Phase I-IV trial contracts.

Emerging players

• Circuit Clinical: Circuit Clinical is a SMO that integrates clinical research into physician practices and health systems, with a focus on patient experience and trial access. Comparable to Hope's investigator-network and community-recruitment model, though smaller and emerging.
• EmVenio Research: EmVenio Research operates community-based and decentralized clinical trial sites focused on diverse and underserved populations. Comparable to Hope's community-led, multilingual recruitment motion and outpatient site model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HopeResearch
• Facebookfacebook.com/HopeResearchInstitute
• LinkedInlinkedin.com/company/hope-research-institute

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hope Research Institute